Align Technology, Inc.(ALGN)Earnings, Financials & Key RatiosAlign Technology, Inc. (ALGN) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the forward P/E of 15.69 appears attractive, the lack of consistent organic revenue growth and the erratic free cash flow margin, which hit a low of 1.4% in 2023Q4, suggest significant execution risk.
Align Technology, Inc. (ALGN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Align Technology, Inc. (ALGN) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $2.58vs $2.30+12.2% | $1.0Bvs $1.0B+1.8% |
| Q1 2026 | Feb 4, 2026 | $3.29vs $2.99+10.0% | $1.0Bvs $1.0B+1.4% |
| Q4 2025 | Oct 29, 2025 | $2.61vs $2.40+8.8% | $996Mvs $976M+2.0% |
| Q3 2025 | Jul 30, 2025 | $2.49vs $2.57-3.1% | $1.0Bvs $1.0B-0.9% |
Recent stock market news and headlines for Align Technology, Inc. (ALGN)
Investors interested in Medical - Dental Supplies stocks are likely familiar with Align Technology (ALGN) and Straumann Holding AG (SAUHY). But which of these two stocks offers value investors a better bang for their buck right now?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that C. Raymond Larkin, Jr. will retire as Chairman of the Board effective July 1, 2026, following more than 20 years of distinguished service on Align's Board of Directors. M.
Key metrics vs top competitors for Align Technology, Inc. (ALGN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $188.39 | $13.49B | 33.34 | 0.9% | 10.17% | 10.39% | — | |
| $12.32 | $2.47B | -4.11 | -2.98% | -17.06% | -41.19% | — | |
| $86.62 | $9.87B | 26.49 | 4.03% | 2.95% | 8.14% | — | |
| $27.51 | $4.48B | 98.25 | 8.32% | 2.41% | 2.18% | — | |
| $564.98 | $44.87B | 43.19 | 10.42% | 24.63% | 70.87% | — | |
| $76.01 | $16.97B | 30.53 | 1.74% | 13.18% | 11.01% | — |
Align Technology, Inc. (ALGN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Align Technology, Inc. (ALGN) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 29, 2026·SEC
Feb 26, 2026·SEC
Feb 4, 2026·SEC
Get notified when ALGN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Align Technology, Inc. (ALGN) stock FAQ — growth, dividends, profitability & financials explained
Align Technology, Inc. (ALGN) reported $4.10B in revenue for fiscal year 2025. This represents a 996442% increase from $0.4M in 1999.
Align Technology, Inc. (ALGN) grew revenue by 0.9% over the past year. Growth has been modest.
Yes, Align Technology, Inc. (ALGN) is profitable, generating $429.9M in net income for fiscal year 2025 (10.2% net margin).
Align Technology, Inc. (ALGN) has a return on equity (ROE) of 10.4%. This is reasonable for most industries.
Align Technology, Inc. (ALGN) generated $716.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
